Quantum-Si incorporated
General ticker "QSI" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $269.4M (TTM average)
Quantum-Si incorporated follows the US Stock Market performance with the rate: 13.6%.
Estimated limits based on current volatility of 3.8%: low 1.31$, high 1.42$
Factors to consider:
- Total employees count: 143 (-13.3%) as of 2024
- US accounted for 39.2% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Limited operating history, Commercialization challenges, Sales and marketing challenges, Geopolitical risks, Regulatory and compliance
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.20$, 2.86$]
- 2025-12-31 to 2026-12-31 estimated range: [1.06$, 2.56$]
Financial Metrics affecting the QSI estimates:
- Positive: with PPE of -3.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -30.22 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 86.91 > 63.39
- Positive: -14.38 < Investing cash flow per share per price, % of -11.25
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: negative Net income
Short-term QSI quotes
Long-term QSI plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $1.08MM | $3.06MM |
| Operating Expenses | $123.84MM | $112.25MM | $111.63MM |
| Operating Income | $-123.84MM | $-111.17MM | $-108.58MM |
| Non-Operating Income | $-8.60MM | $15.21MM | $7.62MM |
| R&D Expense | $72.06MM | $67.03MM | $59.64MM |
| Income(Loss) | $-132.44MM | $-95.96MM | $-100.95MM |
| Taxes | $0.00MM | $0.00MM | $0.06MM |
| Profit(Loss)* | $-132.44MM | $-95.96MM | $-101.01MM |
| Stockholders Equity | $358.71MM | $271.62MM | $215.42MM |
| Inventory | $0.00MM | $3.94MM | $4.07MM |
| Assets | $391.49MM | $298.25MM | $247.87MM |
| Operating Cash Flow | $-90.56MM | $-94.04MM | $-87.80MM |
| Capital expenditure | $10.74MM | $5.27MM | $4.58MM |
| Investing Cash Flow | $137.19MM | $143.43MM | $-32.67MM |
| Financing Cash Flow | $1.91MM | $0.15MM | $35.88MM |
| Earnings Per Share** | $-0.95 | $-0.68 | $-0.71 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.